{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:43:56Z","timestamp":1787071436289,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Growing evidence strongly indicates pivotal roles of gender differences in the occurrence and survival rate of patients with bladder cancer, with a higher incidence in males and poorer prognosis in females. Nevertheless, the molecular basis underlying gender-specific differences in bladder cancer remains unknown. The current study has tried to detect key genes contributing to gender differences in bladder cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The gene expression profile of GSE13507 was firstly obtained from the Gene Expression Omnibus (GEO) database. Further, differentially expressed genes (DEGs) were screened between males and females using R software. Protein\u2013protein interactive (PPI) network analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), and Kaplan\u2013Meier survival analyses were also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We detected six hub genes contributing to gender differences in bladder cancer patients, containing IGF2, CCL5, ASPM, CDC20, BUB1B, and CCNB1. Our analyses demonstrated that CCNB1 and BUB1B were upregulated in tumor tissues of female subjects with bladder cancer. Other genes, such as IGF2 and CCL5, were associated with a poor outcome in male patients with bladder cancer. Additionally, three signaling pathways (focal adhesion, rheumatoid arthritis, and human T-cell leukemia virus infection) were identified to be differentially downregulated in bladder cancer versus normal samples in both genders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings suggested that gender differences may modulate the expression of key genes that contributed to bladder cancer occurrence and prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_280_22","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T02:54:23Z","timestamp":1687920863000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Potential Key Genes Linked to Gender Differences in Bladder Cancer Based on Gene Expression Omnibus (GEO) Database"],"prefix":"10.4103","volume":"12","author":[{"given":"Azam","family":"Rasti","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Abazari","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Dayati","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Kardan","sequence":"additional","affiliation":[{"name":"Department of Cellular Molecular Biology, Faculty of Life Science and Biotechnology, Shahid Beheshti University, Tehran, Qom, Iran"},{"name":"Systems Biology Research Lab, Bioinformatics Group, Systems Biology of the Next Generation Company (SBNGC), Qom, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Salari","sequence":"additional","affiliation":[{"name":"Systems Biology Research Lab, Bioinformatics Group, Systems Biology of the Next Generation Company (SBNGC), Qom, Iran"},{"name":"Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran"},{"name":"Salari Institute of Cognitive and Behavioral Disorders (SICBD), Karaj, Alborz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Khalili","sequence":"additional","affiliation":[{"name":"Department of Urology, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Movahedi","family":"Motlagh","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Modarressi","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: A systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: An update","volume":"38","author":"Richters","year":"2020","journal-title":"World J Urol"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/551S33a","article-title":"Bladder cancer","volume":"551","author":"Grayson","year":"2017","journal-title":"Nature"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MOU.0000000000000543","article-title":"Biology of nonmuscle-invasive bladder cancer: Pathology, genomic implications, and immunology","volume":"28","author":"Dyrskj\u00f8t","year":"2018","journal-title":"Curr Opin Urol"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"e213800","DOI":"10.1001\/jamanetworkopen.2021.3800","article-title":"Estimated costs and long-term outcomes of patients with high-risk non\u2013muscle-invasive bladder cancer treated with Bacillus Calmette-Gu\u00e9rin in the veterans affairs health system","volume":"4","author":"Williams","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R7-20240830","first-page":"15","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med Sci (Basel)"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clgc.2019.10.020","article-title":"Sex differences in urothelial bladder cancer survival","volume":"18","author":"Radkiewicz","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/iju.IJU_320_19","article-title":"Clinical and therapeutic implications of sex steroid hormone receptor status in urothelial bladder cancer","volume":"36","author":"Moorthy","year":"2020","journal-title":"Indian J Urol"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOU.0000000000000606","article-title":"The impact of gender on oncologic outcomes of bladder cancer","volume":"29","author":"Mun","year":"2019","journal-title":"Curr Opin Urol"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"e13847","DOI":"10.1097\/MD.0000000000013847","article-title":"CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"3917982","DOI":"10.1155\/2019\/3917982","article-title":"Bioinformatics analysis identified key molecular changes in bladder cancer development and recurrence","volume":"2019","author":"Chen","year":"2019","journal-title":"BioMed Res Int"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3389\/fgene.2019.00695","article-title":"Identification of potential crucial genes and key pathways in breast cancer using bioinformatic analysis","volume":"10","author":"Deng","year":"2019","journal-title":"Front Genet"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2014analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: A comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2019.12.021","article-title":"Sensitization to oxidative stress and G2\/M cell cycle arrest by histone deacetylase inhibition in hepatocellular carcinoma cells","volume":"147","author":"Lee","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijbiomac.2018.11.032","article-title":"Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53\/FoxM1\/CCNB1 pathway and predicts poor prognosis in bladder cancer","volume":"123","author":"Liu","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"0300060520980647","DOI":"10.1177\/0300060520980647","article-title":"Expression and prognostic value of CDK1, CCNA2, and CCNB1 gene clusters in human breast cancer","volume":"49","author":"Xing","year":"2021","journal-title":"J Int Med Res"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fonc.2019.00613","article-title":"Identification of biomarkers for controlling cancer stem cell characteristics in bladder cancer by network analysis of transcriptome data stemness indices","volume":"9","author":"Pan","year":"2019","journal-title":"Front Oncol"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fgene.2019.00408","article-title":"Identification of hub genes associated with progression and prognosis in patients with bladder cancer","volume":"10","author":"Yan","year":"2019","journal-title":"Front Genet"},{"key":"R23-20240830","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1530\/ERC-13-0231","article-title":"IGF2 and cancer","volume":"20","author":"Livingstone","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"R24-20240830","doi-asserted-by":"crossref","first-page":"e0178885","DOI":"10.1371\/journal.pone.0178885","article-title":"IGF1 and IGF2 specificities to the two insulin receptor isoforms are determined by insulin receptor amino acid 718","volume":"12","author":"Andersen","year":"2017","journal-title":"PLoS One"},{"key":"R25-20240830","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/1878-0261.12164","article-title":"Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation","volume":"12","author":"K\u00fcffer","year":"2018","journal-title":"Mol Oncol"},{"key":"R26-20240830","first-page":"3621","article-title":"Long non-coding RNA DANCR upregulates IGF2 expression and promotes ovarian cancer progression","volume":"23","author":"Gao","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R27-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23052-9","article-title":"Disruption of FOXO3a-miRNA feedback inhibition of IGF2\/IGF-1R\/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer","volume":"12","author":"Luo","year":"2021","journal-title":"Nature Commun"},{"key":"R28-20240830","doi-asserted-by":"crossref","first-page":"255","DOI":"10.21608\/bjas.2021.169460","article-title":"Evaluation of IGF-2 gene expression in urine and its potential use as biomarker for bladder cancer","volume":"6","author":"El-Abd","year":"2021","journal-title":"Benha J Appl Sc"},{"key":"R29-20240830","first-page":"1","article-title":"CCR5\/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells","volume":"8","author":"Singh","year":"2018","journal-title":"Sci Rep"},{"key":"R30-20240830","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3390\/cancers12071765","article-title":"The CCL5\/CCR5 axis in cancer progression","volume":"12","author":"Aldinucci","year":"2020","journal-title":"Cancers"},{"key":"R31-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-021-00938-w","article-title":"Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: Evidence from comprehensive bioinformatic analysis","volume":"21","author":"Li","year":"2021","journal-title":"BMC Urol"},{"key":"R32-20240830","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pharmthera.2015.04.002","article-title":"Targeting Cdc20 as a novel cancer therapeutic strategy","volume":"151","author":"Wang","year":"2015","journal-title":"Pharmacol Ther"},{"key":"R33-20240830","first-page":"2250","article-title":"CDC20 associated with cancer metastasis and novel mushroom-derived CDC20 inhibitors with antimetastatic activity","volume":"54","author":"Cheng","year":"2019","journal-title":"Int J Oncol"},{"key":"R34-20240830","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2020.11.052","article-title":"Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation","volume":"500","author":"Wang","year":"2021","journal-title":"Cancer Lett"},{"key":"R35-20240830","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00428-013-1473-6","article-title":"High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer","volume":"463","author":"Choi","year":"2013","journal-title":"Virchows Arch"},{"key":"R36-20240830","first-page":"1865","article-title":"Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer","volume":"17","author":"Xu","year":"2019","journal-title":"Oncol Lett"},{"key":"R37-20240830","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11255-017-1545-7","article-title":"High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer","volume":"49","author":"Xie","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"R38-20240830","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fonc.2019.00310","article-title":"Overexpression of ASPM, CDC20, and TTK confer a poorer prognosis in breast cancer identified by gene co-expression network analysis","volume":"9","author":"Tang","year":"2019","journal-title":"Front Oncol"},{"key":"R39-20240830","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/kjm2.12284","article-title":"ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer","volume":"36","author":"Gao","year":"2020","journal-title":"Kaohsiung J Med Sci"},{"key":"R40-20240830","doi-asserted-by":"crossref","first-page":"4070419","DOI":"10.1155\/2020\/4070419","article-title":"Molecular mechanisms contributing bacterial infections to the incidence of various types of cancer","volume":"2020","author":"Sheweita","year":"2020","journal-title":"Mediators Inflamm"},{"key":"R41-20240830","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcimb.2018.00167","article-title":"Profiling the urinary microbiota in male patients with bladder cancer in China","volume":"8","author":"Wu","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"R42-20240830","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_280_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:46:08Z","timestamp":1787067968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_280_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_280_22","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2022-08-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}